Abstract:Upon immune activation, in addition to the first signal driven by the TCR-peptide/MHC interactions, the costimulatory signals are indispensable to optimal T-cell activation, the absence of which will trigger naive T cells to an anergic state. The CD28-CD80/CD86 pathway is widely known as the most classical and critical costimulatory signal for the initial activation of T cells. Bispecific T-cell engagers targeting CD3e can activate cytotoxic T-cells and have shown remarkable tumor regressions in clinical trials. However, the absence of a costimulatory signal through CD28 results in insufficient T-cell activation and early exhaustion. Combination of both CD3e and CD28 targeting antibodies offers attractive approach to optimally boost T-cell activity. Development of superagonistic CD28-targeting antibody has been paused after TeGenero's TGN1412 Phase 1 trial in 2006 due to life-threatening cytokine release syndrome. Unlike superagonist TGN1412, which activates T cells and induce cytokine storm, tumor targeting antigen and cross-linking dependent CD28 bispecific antibody is supposed to display little or no toxicity. In the present study, we explored Alpaca immunized phage library approach to generate cross-linking dependent agonist CD28 single domain antibody for bispecific antibody development. Alpacas were immunized subsequently with recombinant human CD28 extracellular domain and 293F cells stably expressing human CD28. Serum samples after immunizations showed decent immune response against CD28. At the end of Boost 2 and 3, peripheral blood was collected and phage display libraries were constructed using VHH specific primers. Phage display libraries were panned against recombinant CD28 ECD protein and CHOK1 cells overexpressing CD28. After one round of panning, both protein and cell panning tracks showed robust enrichment in output titer and repeating sequences. Next, 600 clones were randomly picked for screening by the binding to U266B1 cells endogenously expressing CD28. Of the 326 clones showed positive binding to U266B1, 79 unique sequences were identified. Secondary screening by ELISA and FACS using periplasmic extract confirmed 69 unique sequences that bound to both CD28 protein and cells expressing CD28. Seventeen unique sequences were selected for VHH-Fc production. All purified VHH-Fc showed sub-nanomolar affinity by ELISA and bind to primary T cells by flow cytometry. Three VHH-Fc induced IL-2 production in a primary T cells activation assay only when cross-linked and in the presence of CD3 co-stimulation and are suitable for further bispecific T cell engager development. Citation Format: Yunyun Chen, Yannan Ding, Xiaoyan Liu, Qianqian Zhu, Wenfang Xin, Hu Liu, Teddy Yang, Yikai Qiu. Discovery of agonist CD28-specific single domain antibodies from alpaca [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2479.

Construction and Biopanning of Camelid Naive Single-domain Antibody Phage Display Library

Construction of Alpaca-derived Naive Single-domain Antibody Phage Display Library by Semi-nested PCR

Construction and Characterization of a Non-Immune Llama Variable Heavy Chain Phage Display Antibody Library

Development, High-Throughput Profiling, and Biopanning of a Large Phage Display Single-Domain Antibody Library

Construction of yeast surface display library for single domain antibody against porcine C-type lectin domain family 8, member A receptor

Construction and validation of a synthetic phage-displayed nanobody library

Construction of an alpaca immune antibody library for the selection of nanobodies against Drosophila melanogaster proteins

A Novel VHH Antibody Targeting the B Cell-Activating Factor for B-cell Lymphoma.

Construction and Diversity Analysis of a Na(i)ve Human Phage-Displayed Fab Library

Construction and preliminary application of a human natural phage antibody library with diversity]

Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries

Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies

Semisynthetic Phage Display Library Construction: Design and Synthesis of Diversified Single-Chain Variable Fragments and Generation of Primary Libraries

Construction and Screening of a Phage Display Library of Repertoire Single Chain Antibody from Mouse Immunized with Vwf-A1

Abstract 2479: Discovery of agonist CD28-specific single domain antibodies from alpaca

Construction of a Single Chain Fv Phage Display Library Against Human B-lymphoma

Designing and constructing a phage display synthesized single domain antibodies library based on camel VHHs frame for screening and identifying humanized TNF-α-specific nanobody

Phage-displayed synthetic library and screening platform for nanobody discovery

Landscape of Variable Domain of Heavy‐chain‐only Antibody Repertoire from Alpaca

[Rapid Construction of a Mammalian Cell Surface Display Library of Full-Length Human Antibodies].